Top stock picks for capital appreciation and outperformance, with a focus on profits, dividends, and long-term viability. Click for more on Capital Appreciation.
Cendakimab fell short of the bar. The antibody hits IL-13, one of the interleukins targeted by Regeneron and Sanofi’s ...
Wedgewood, the nation’s largest provider of compounded veterinary medications and pharmacy solutions, has appointed Stanley ...
Shares in Bristol-Myers Squibb traded lower after the drug maker gave 2025 guidance that undershot expectations. Bristol expects sales of about $45.5 billion in 2025, compared with the $46.3 billion ...
Shares in Bristol-Myers Squibb fell more than 4% in premarket trading Thursday, after the drug maker gave 2025 guidance that undershot analyst expectations. Bristol expects sales of about $45.5 ...
The Biospecimen Management Consortium (BMC), launched in June 2024 to drive sample excellence in clinical research, is pleased to announce significant progress in its mission to revolutionize ...
Offshoots of the RSS such as the Swadeshi Jagran Manch that push for indigenisation, the Bharatiya Mazdoor Sangh, the Sangh’s labour wing, and the Bharatiya Kisan Sangh that is a collective of farm ...
FFO, a key performance measure for REITs, came in at $411.8 million, or $2.39 per share, for the quarter, compared with $389.8 million, or $2.28 per share, a year ago. Its total revenue for the ...
Ozanimod▼ is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (RRMS) with active disease as defined by clinical or imaging features. Ozanimod® is subject to ...
Caroline LupiniManaging Editor, Credit Cards & Travel Rewards Caroline Lupini has been traveling the world with the help of credit card rewards since 2011. She has visited over 110 countries and ...
You're in the right place. Our team has sifted through hundreds of cards to find the absolute best, tailoring our picks to what cardholders like you want most. Whether you're chasing cash back ...
'ZDNET Recommends': What exactly does it mean? ZDNET's recommendations are based on many hours of testing, research, and comparison shopping. We gather data from the best available sources ...